Filing Details

Accession Number:
0001363213-14-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-18 18:44:47
Reporting Period:
2013-08-31
Filing Date:
2014-03-18
Accepted Time:
2014-03-18 18:44:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880771 Sciclone Pharmaceuticals Inc SCLN Pharmaceutical Preparations (2834) 943116852
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1363213 Friedhelm Blobel 950 Tower Lane, Suite 900
Foster City CA 94404
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-08-31 1,000 $4.24 48,036 No 4 P Direct
Common Stock Acquisiton 2013-11-30 1,000 $4.15 49,036 No 4 P Direct
Common Stock Acquisiton 2014-02-28 1,000 $3.95 50,036 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2014-03-14 200,000 $0.00 200,000 $4.52
Common Stock Restricted Stock Unit Acquisiton 2014-03-14 7,000 $0.00 7,000 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
200,000 2024-03-14 No 4 A Direct
266,034 No 4 A Direct
Footnotes
  1. Purchased under the Issuer's Employee Stock Purchase Plan on August 31, 2013.
  2. Purchased under the issuer's Employee Stock Purchase Plan on November 30, 2013.
  3. Purchased under the Issuer's Employee Stock Purchase Plan on February 28, 2014.
  4. Granted under the Issuer's 2005 Equity Incentive Plan.
  5. 25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
  6. Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
  7. Vesting for such RSUs will occur 50% on February 20, 2015 and 50% on February 20, 2016, or on such later date thereafter as the Company's trading window opens if it is not open on either of such dates.